As demonstrated in pancreatic adenocarcinoma, the loss of tumor suppressor SMAD4/DPC4 has been identified in BilN and IPNB precursor lesions and has been implicated in carcinogenesis. This evidence concerns the gene SMAD4 and pancreatic adenocarcinoma.